Evo-2登上Nature：AI模型实现对所有生命基因组的建模和设计，甚至能从头设计生命

Core Viewpoint - The article discusses the groundbreaking AI model Evo-2, which represents a significant advancement in biological AI, capable of understanding, modeling, and designing genetic codes across all domains of life, utilizing vast genomic data and advanced machine learning techniques [2][3][12]. Group 1: Evo-2 Overview - Evo-2 is the largest biological AI model to date, trained on 128,000 genomes comprising 9.3 trillion nucleotides, enabling comprehensive understanding and design of genetic codes [3][12]. - The model was developed through collaboration with researchers from Stanford University, UC Berkeley, UCSF, and NVIDIA, utilizing over 2,000 NVIDIA H100 GPUs [3][12]. - Evo-2 is fully open-source, allowing global researchers to access and deploy it via the NVIDIA BioNeMo platform, facilitating exploration and design in biological complexity [3][28]. Group 2: Technical Innovations - Evo-2 employs a new architecture called StripedHyena 2, which enhances training speed and inference efficiency, allowing it to process DNA sequences of up to 1 million base pairs [14]. - The model's training parameters reach up to 40 billion, significantly expanding its predictive capabilities compared to its predecessor, Evo [12][14]. Group 3: Predictive and Generative Capabilities - Evo-2 excels in zero-shot prediction of gene mutation impacts, demonstrating high accuracy in predicting splice mutations and outperforming many zero-shot models [16][20]. - The model can generate complete genomic sequences, including those for mitochondrial genomes and yeast chromosomes, showcasing its generative capabilities [18][21]. Group 4: Applications in Medicine and Synthetic Biology - Evo-2's predictive abilities are crucial for clinical diagnostics, particularly in assessing mutations in genes like BRCA1 and BRCA2, which are vital for breast cancer risk evaluation [23]. - The model's generative capabilities open new avenues in synthetic biology, allowing researchers to design DNA sequences with specific functions, such as creating custom regulatory elements [24]. Group 5: Open Ecosystem and Ethical Considerations - The open-source nature of Evo-2 addresses long-standing issues in the biological computing field, promoting a unified platform for innovation and application development [28][29]. - The research team has implemented safety measures by excluding viral sequences that could infect eukaryotic organisms, reflecting a commitment to ethical considerations in AI applications [31].